Skip to main content

Rathbones Group PLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1351991 Liverpool, X0

Position in LCTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$55,300
-$3,150 QoQ
Shares Held
35,000
0.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Rathbones Group PLC holds $8,220,550 across 18 Biotechnology names. LCTX ranks #16 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LCTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $55,300 35,000
2025-12-31 $58,450 35,000
2025-09-30 $59,150 35,000
2025-06-30 $31,850 35,000
2025-03-31 $15,750 35,000
2024-12-31 $17,500 35,000
2024-09-30 $31,850 35,000
2024-06-30 $35,000 35,000
2024-03-31 $51,800 35,000
2023-12-31 $38,150 35,000
2023-09-30 $41,300 35,000